ALPS
Price
$0.65
Change
-$0.03 (-4.41%)
Updated
Jun 23, 02:33 PM (EDT)
Capitalization
113.15M
Intraday BUY SELL Signals
APLM
Price
$20.09
Change
-$2.74 (-12.00%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
50.14M
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPS vs APLM

ALPS vs APLM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALPS vs. APLM commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPS is a Hold and APLM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ALPS: $0.68 vs. APLM: $22.83)
Brand notoriety: ALPS and APLM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALPS: 16% vs. APLM: 391%
Market capitalization -- ALPS: $113.15M vs. APLM: $50.14M
ALPS [@Biotechnology] is valued at $113.15M. APLM’s [@Biotechnology] market capitalization is $50.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPS’s FA Score shows that 1 FA rating(s) are green whileAPLM’s FA Score has 0 green FA rating(s).

  • ALPS’s FA Score: 1 green, 4 red.
  • APLM’s FA Score: 0 green, 5 red.
According to our system of comparison, APLM is a better buy in the long-term than ALPS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPS’s TA Score shows that 4 TA indicator(s) are bullish while APLM’s TA Score has 5 bullish TA indicator(s).

  • ALPS’s TA Score: 4 bullish, 4 bearish.
  • APLM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, APLM is a better buy in the short-term than ALPS.

Price Growth

ALPS (@Biotechnology) experienced а -11.68% price change this week, while APLM (@Biotechnology) price change was +64.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALPS($113M) has a higher market cap than APLM($50.1M). APLM YTD gains are higher at: 22.118 vs. ALPS (-21.785).
ALPSAPLMALPS / APLM
Capitalization113M50.1M226%
EBITDAN/A-56.38M-
Gain YTD-21.78522.118-98%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/AN/A-
Total DebtN/A4.72M-
TECHNICAL ANALYSIS
Technical Analysis
ALPSAPLM
RSI
ODDS (%)
Bullish Trend 2 days ago
29%
Bearish Trend 2 days ago
30%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
23%
Bearish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
21%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bullish Trend 2 days ago
31%
Bullish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
32%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
33%
Bullish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 9 days ago
53%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
68%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
30%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bearish Trend 2 days ago
48%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ALPS
Daily Signal:
Gain/Loss:
APLM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARIIX11.18N/A
N/A
AB Global Real Estate Investment II I
SHSAX62.83N/A
N/A
BlackRock Health Sciences Opps Inv A
NMCAX17.03N/A
N/A
Voya MidCap Opportunities A
SSCOX6.45N/A
N/A
Touchstone Small Company C
MSHOX12.36N/A
N/A
Morgan Stanley Inst Permanence C

ALPS and

Correlation & Price change

A.I.dvisor tells us that ALPS and NUVL have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALPS and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPS
1D Price
Change %
ALPS100%
-5.56%
NUVL - ALPS
21%
Poorly correlated
-0.02%
ALNY - ALPS
17%
Poorly correlated
+2.99%
APLM - ALPS
12%
Poorly correlated
+30.47%
SGMT - ALPS
9%
Poorly correlated
+6.29%
GDTC - ALPS
8%
Poorly correlated
N/A
More